Intravenous beta2‐agonists versus intravenous aminophylline for acute asthma

Overview of attention for article published in Cochrane database of systematic reviews, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 1 news story.

I believe MediciNova (NASDAQ: MNOV ) is a disastrous investment based on its long history of failed science, self-enrichment by…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.